Human Pancreatic Carcinoma Cells Activate Maspin Expression Through Loss of Epigenetic Control

Neoplasia

Volumn 5, Issue 5, 2003, Pages 427-436

  Fitzgerald, Matthew ^a   Oshiro, Marc ^b   Holtan, Nicholas ^b   Krager, Kimberly ^a   Cullen, Joseph J ^a,c   Futscher, Bernard W ^b   Domann, Frederick E ^a,c,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Cancer; DNA methylation; Gene expression; Histone acetylation; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; CYTOSINE; HISTONE H3; HISTONE H4; MASPIN;

ACETYLATION; ARTICLE; CARCINOMA CELL; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASPIN GENE; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0344827241     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(03)80045-3     Document Type: Article

References (33)

1. Holliday R, and Pugh JE (1975). DNA modification mechanisms and gene activity during development. Science 187, 226-32.
2. Riggs AD (1975). X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet 14, 9-25.
3. Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, and Domann FE (2002). Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 31, 175-79.
4. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, and Sager R (1994). Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526-29.
5. Sager R, Sheng S, Pemberton P, and Hendrix MJ (1996). Maspin: a tumor suppressing serpin. Curr Top Microbiol Immunol 213, 51-64.
6. Ngamkitidechakul C, Burke JM, O'Brien WJ, and Twining SS (2001). Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. Invest Ophthalmol Vis Sci 42, 3135-141.
7. Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K, and Rudolph P (2001). Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 195, 321-26.
8. Sheng S, Pemberton PA, and Sager R (1994). Production, purification, and characterization of recombinant maspin proteins. J Biol Chem 269, 30988-993.
9. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA, and Hendrix MJC (2002). The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8, 2924-932.
10. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A, and Rickert P (2002). Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21, 7749-763.
11. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W, and Nagasaki K (2001). Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 7, 812-17.
12. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, and Hanash S (2003). Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63, 2649-57.
13. Domann FE, Rice JC, Hendrix MJ, and Futscher BW (2000). Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85, 805-10.
14. Maass N, Biallek M, Rosel F, Schem C, Ohike N, Zhang M, Jonat W, and Nagasaki K (2002). Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 297, 125-28.
15. Clark SJ, Harrison J, Paul CL, and Frommer M (1994). High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22, 2990-997.
16. Zhang M, Maass N, Magit D, and Sager R (1997). Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ 8, 179-86.
17. Rice JC, and Futscher BW (2000). Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res 28, 3233-239.
18. Domann FE, and Futscher BW (2003). Editorial: maspin as a molecular target for cancer therapy. J Urol 169, 1162-164.
19. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, and Halnaut P (2002). The IARC TP53 database: new online mutation analysis and recommendation to users. Hum Mutat 19, 607-14.
20. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, and Srivastava S (2000). p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275, 6051-6054.
21. Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, and Futscher BW (2003). Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 22, 3624-634.
22. Fischle W, Wang Y, and Allis CD (2003). Histone and chromatin crosstalk. Curr Opin Cell Biol 15, 172-83.
23. Ng HH, and Bird A (1999). DNA methylation and chromatin modification. Curr Opin Genet Dev 9, 158-63.
24. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, and Wolffe AP (1999). Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23, 62-66.
25. Son HJ, Sohn TS, Song SY, Lee JH, and Rhee JC (2002). Maspin expression in human gastric adenocarcinoma. Pathol Int 52, 508-13.
26. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, and Sager R (1996). Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93, 11669-674.
27. Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R, and Hendrix MJ (1998). Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 58, 5681-685.
28. Zhang M, Volpert O, Shi YH, and Bouck N (2000). Maspin is an angiogenesis inhibitor. Nat Med 6, 196-99.
29. Jones PA, and Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-28.
30. Baylin SB, and Herman JG (2000). DNA hypermethylation in tumori-genesis: epigenetics joins genetics. Trends Genet 16, 168-74.
31. Maass N, Rolver L, Ziebart M, Nagasaki K, and Rudolph P (2002). Maspin locates to the nucleus in certain cell types. J Pathol 197, 273-74.
32. Boyer B, Valles AM, and Edme N (2000). Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60, 1091-1099.
33. Vincent-Salomon A, and Thiery JP (2003). Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 5, 101-106.